Chronic kidney disease in combination with chronic obstructive pulmonary disease under lowmountain conditions: risk factors, early detection and clinical and functional features


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The concomitant pathology of the renal system often can lead to a mutual burden of various pathology of other organs and systems. Such a proposal requires additional and detailed examination of the urogenital system in patients with chronic obstructive pulmonary disease (COPD). the adequate preventive measures in combination with a more thorough and correct drug therapy in the future will favorably affect the quality of life, and also delay the start of renal replacement therapy. Purpose. This work is devoted to the analysis of the continuity of risk factors for development, early detection and clinical and functional features of chronic kidney disease (CKD) in patients with copd under low-mountain conditions (Tokmok, Kyrgyz republic) at earlier stages of its manifestation. material and methods. we examined 82 patients with copd of varying severity, as well as io healthy individuals in low mountains (Tokmok). the mean age of the examined patients was 60.53±15.48 years. at the same time, we analyzed the data of general clinical examination characteristic of each of these nosological units. we also evaluated respiratory function and renal function, including the following parameters: marker of early renal damage, moderately increased albuminuria, glomerular filtration rate, proteinuria, leukocyturia, hematuria, total protein, and serum creatinine levels. Taking into account risk factors for the development of ckd, we determined such parameters as the age of patients, body mass index, smoking index, the main indicator used to calculate the frequency of smoking, as well as anamnestic data on birth weight. results. patients suffering from copd had risk factors for developing ckd, and they also showed early and significant changes in the renal system, correlating with the degree of bronchial obstruction. Conclusion Risk factors for the development of ckd detected in the early stages, as well as signs of the pathology of the renal system in patients with copd, require additional examination, which will serve for a future prevention and further correct nephroprotective therapy at earlier stages.

Full Text

Restricted Access

About the authors

D. V Dolgalev

International Higher School of Medicine

Email: dolgalyovd@mail.ru
Teaching Assistant at the Department of Internal Diseases Bishkek, Kyrgyzstan

R. R Kaliev

I.K. Akhunbaev Kyrgyz State Medical Academ

Doctor of Medical Sciences, Professor Bishkek, Kyrgyzstan

References

  1. Ford E.S., Murphy L.B., Khavjou O. Total and state-specific medical and absenteeism costs of COPD among adults aged >18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31-45.
  2. Global Initiative for Chronic Obstructive Lung Disease, Inc. (revised 2011).
  3. Couser W.G., et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258-70.
  4. Lopez A., et al. Global burden of disease and risk factors. Oxford University Press. 2006.
  5. Coresh J, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003;41(1):1-12.
  6. Hallan S.I., et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J. Am. Soc. Nephrol. 2006;17(8):2275- 2284.
  7. Chadban S.J., et al. Prevalence of kidney damage in Australian adults: The Aus Diab Kidney Study. J. Am. Soc. Nephrol. 2003;14: S131-238.
  8. Choudhury D., Ahmed Z. Drug-associated renal dysfunction and injury. Nature clinical practice. Nephrology. 2006;2(2):80-91.
  9. De Jager D.J, et al. Association between time of referral and survival in the first year of dialysis in diabetics and the elderly. Nephrol. Dial. Transplant. 2011;26(2):652-658.
  10. Jungers P, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol. Dial. Transplant. 2001;16(12):2357-64.
  11. Mendelssohn D.C., Malmberg C., Hamandi B. An integrated review of “unplanned” dialysis initiation: reframing the terminology to “suboptimal” initiation. BMC Nephrology. 2009;10:22.
  12. Болотова Е.В., Дудникова А.В. Особенности факторов риска хронической болезни почек у пациентов с хронической обструктивной болезнью легких. Нефрология. 2015;19(5):28-33.
  13. Болотова Е.В., Дудникова А.В. Хроническая болезнь почек у пациентов с хронической обструктивной болезнью легких: роль частоты обострений. Пульмонология. 2016;26(5):578-583.
  14. Умеренно увеличенная альбуминурия является наиболее ранним маркером проявления почечного повреждения при ХОБЛ, отмечается у пациентов с легким течением, а далее имеет тенденцию к нарастанию по мере прогрессирования ХОБЛ.
  15. Более существенные и значимые изменения показателей ренальной функции наблюдаются у пациентов с ХОБЛ в условиях низкогорья и коррелируют со степенью бронхиальной обструкции.
  16. Долгополова Д.А. Предикторы развития хронической болезни почек у больных хронической обструктивной болезнью легких. Клиницист. 2016;10(3):51-7.
  17. Smart N.A., Titus T.T. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am. J. Med. 2011;124(11):1073- 1080.
  18. Chuahirun T., Khanna A., Kimball K., et al. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Kidney Dis. 2003;41:13-1.
  19. Hemlin M., Ljungman S., Carlson J., et al. The effects of hypoxia and hypercapnia on renal and heartfunction, haemodynamics and plasma hormone levels in stable COPD patients. Clin. Respir. 2007;1(2):80-90.
  20. Parving H.H. Initiation and progression of diabetic nephropathy. N. Engl. J. Med. 1996;335:1682-1683.
  21. Ruilope L.M., Rodicio J.L. Clinical relevance of proteinuria and microalbuminuria. Curr. Opin. Nephrol. Hypertens. 1993;2:962-967.
  22. Hellege H.L., Fidler V., Diercks G.,F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-1782.
  23. Вiine E., Ekici M., Ekici A., Kisa U. Microalbuminuria in chronic obstructive pulmonary disease. COPD. 2013;10(2):92-186.
  24. Casanova C., Torres J.P., Navarro J., et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Respir. Crit. Care Med. 2010;182(8):1004-1010.
  25. Вiine E., Ekici M., Ekici A., et al. Microalbuminuria in obstructive sleep apnea syndrome. Sleep Breath 2015. [Epub. ahead of print].
  26. Долгалев Д.В., Ибрагимов А.А., Калиев Р.Р. Функциональное состояние почек при хронической обструктивной болезни легких в условиях низкогорья. Вестн. КГМА. 2015;3:57-61.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies